InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Hall Ashley. Insider active across 2 companies, notably Reneo Pharmaceuticals, Inc.. Cumulatively, 7 disclosures have been logged. Activity tracked since 12 November 2021. The latest transaction was filed on 19 March 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Hall Ashley is a declarant linked to Structure Therapeutics Inc. and Reneo Pharmaceuticals, Inc., where the listed role is Chief Development Officer. The record shows 7 filings in total, and among the recent filings tracked, the activity runs from 2021-11-15 to 2026-03-23, with a modal transaction nature of Attribution and buy and sell amounts at EUR 0.